The Signal-Seeker™ line of produts have been developed to allow simple analysis of key regulatory protein modifications by specialists and non-specialists alike. The comprehensive Signal-Seeker™ kits provide an affinity bead system to isolate and enrich modified proteins from any given cell or tissue lysate. The enriched protein population is then analyzed by standard western blot procedures using a primary antibody to the target protein.
Product Uses Include
- Investigate transient regulatory mechanisms
- Measure signalling events of multiple pathway member proteins
- Discover new modifications of your protein of interest
- Gain insight into regulatory mechanisms
- Measure endogenous or transiently expressed protein signalling events
Validation Data: SUMOylation 2/3 Detection Kit White Paper
Kit contents
The SUMOylation 2/3 kit contains the following components:
| Lysis and protein quantitation step | IP and pre-clear step | Wash step | Elution step | Western step |
BlastR™ Lysis Buffer BlastR™ Dilution Buffer BlastR™ Filters Protease Inhibitor Cocktail De-SUMOylation inhibitor Cocktail Precision Red™ Protein Assay Reagent | SUMOylation 2/3 Affinity Beads IP Control Beads
| BlastR™ Wash Buffer
| Spin Columns Bead Elution Buffer
| Chemiluminescent Reagent A Chemiluminescent Reagent B Anti-SUMO2/3-HRP antibody
|
Example results
There are many applications for these kits, here we describe an interesting example:
Application 1: Investigate significant SUMOylation 2/3 events
Immunoprecipitation using the Signal-Seeker™ SUMOylation 2/3 Detection Kit
Denatured cell lysates were prepared as previously reported1 from HeLa cells ("HS43": Heat Shock treated 42°C for 10 min, and "CT37": untreated) and HeLa siRNA SUMO knockdown ("KDS2"). 1mg of lysate was used for the immunoprecipitation (IP) of SUMOylated 2/3 proteins. Western blots of immunoprecipitated proteins were developed using anti-SUMO-2/3 antibody (Cytoskeleton cat# ASM23) (A) or anti-Ubc9 antibody (B). The level of SUMO-2/3 conjugates in heat shock treated cells is higher than control, and shRNA SUMO-2 knock-down reduced the level of SUMOylated 2/3 modified proteins. Chemical conjugation of SUMO-2/3 antibody (11G2) to the affinity bead matrix prevents heavy and light chain leaching. Unconjugated free SUMO is also captured by the SUMO-2/3 affinity beads.
(B) Unmodified Ubc9 is visible near 18kDa. High molecular-weight band indicates that Ubc9 is SUMOylated by a single SUMO-2/3 protein. Ubc9 has previously been reported to be a target for SUMOylation1,2.
1. Barysch S. et al. 2014. Identification and analysis of endogenous SUMO1 and SUMO2/3 targets in mammalian cells and tissues using monoclonal antibodies. Nat Protoc. 9(4):896-909
2. Becker J. et al. 2013. Detecting endogenous SUMO targets in mammalian cells and tissues. Nature Struc. & Mol. Biol. 20, 525-531.
• Pharmacological investigation of SUMOylating and de-SUMOylating enzymes involved in regulation of target proteins.
• Investigate SUMOylation under a variety of different growth factors or drug treatments.
• Examine the interaction of SUMOylated target proteins with its downstream effectors.
• Examine crosstalk between SUMOylation 2/3 and other PTMs for target proteins.
For more information contact: signalseeker@cytoskeleton.com
Associated Products:
Signal-Seeker™ Phosphotyrosine Detection Kit (Cat. # BK160)
Signal-Seeker™ Ubiquitination Detection Kit (Cat. # BK161)
Signal-Seeker™: BlastR™ Rapid Lysate Prep Kit (Cat. # BLR01)
Signal-Seeker™ SUMOylation 2/3 Affinity Beads (Cat.# ASM24-beads)
Signal-Seeker™: PTMtrue™ SUMOylation 2/3 Antibody (Cat.# ASM23)
Click on the pdf icon below to download the manual 
For the most recent publications citing this and other Signal-Seeker™ products, see our Signal-Seeker™ Validation Data Page click here
Visit our Signal-Seeker™ Tech Tips and FAQs page for technical tips and frequently asked questions regarding this and other Signal-Seeker™ products click here
If you have any questions concerning this product, please contact our Technical Service department at tservice@cytoskeleton.com
ebiomall.com
>
>
>
>
>
>
>
>
>
>
>
>
逆转录（reverse transcription）是以RNA为模板合成DNA的过程，即RNA指导下的DNA合成。此过程中，核酸合成与转录（DNA到RNA）过程与遗传信息的流动方向（RNA到DNA）相反，故称为逆转录。逆转录过程是RNA病毒的复制形式之一，需逆转录酶的催化。 逆转录过程的揭示是分子生物学研究中的重大发现，是对中心法则的重要修正和补充。人们通过体外模拟该过程，以样本中提取的mRNA为模板，在逆转录酶的作用下，合成出互补的cDNA，构建cDNA文库，并从中筛选特异的目的基因。该方法已成为基因工程技术中最常用的获得目的基因的策略之一。
首先，不否认它比大多数国产的试剂盒做得好，提取的纯度、方便度和量，都还很不错。
其次，它是日本的。so我觉得实验室用用天根的，就非常好了。拒绝日货，从实验室做起。
向左转|向右转
一、cDNA第二链的合成:
1. 第一链反应完成后,取2ul一链产物－20℃冰箱中保存，待电泳检测。其余的产物合并，混匀，然后顺序加入下列试剂(promega):
20ul 10×DNA Polymerase I buffer
6ul10mM dNTP(自己配制)
xuldd H2O
1ulRNase H(2U/ul)
10ul DNA Polymerase I(10U/ul)
总体系为200ul;
2. 混匀后,16℃反应2.5小时;
3. 70℃灭活10分钟;
4. 反应完成后,得到200ul cDNA第二链反应体系,将此体系置于冰上;
5．取2ul二链产物，同保存的一链产物一起电泳鉴定。同时上1kb ladder，确定双链的大小范围。
注：一链，二链的电泳图是smear，且二链稍比一链大一些。
二、双链cDNA末端补平:
1. 在第二链反应体系中,顺序加入下列试剂(promega):
6ul 10mM dNTP
2ul T4 DNA Polymerase(8.7U/ul)
2ul BSA(10mg/ml)
2. 稍微离心混匀反应物, 37℃反应至少30分钟,然后75℃灭活10分钟;
3. 加入等体积酚/氯仿/异戊醇,剧烈振荡后,常温下13000g离心5分钟;
4. 离心后,吸取上清于另一1.5ml eppendof管中,加入等体积氯仿,上下颠倒几次混匀后,常温下13000g离心5分钟;
5. 吸取上清至另一eppendof管,加入1/10V3M NaAc(PH5.2)和2.5V预冷的无水乙醇,混匀,-20℃放置过夜以沉淀双链cDNA;
6. 第二日,将昨日沉淀物在4℃,13000g离心60分钟以充分沉淀双链cDNA;
7.离心完毕,弃上清,加入1ml 70%乙醇洗涤沉淀,常温下13000g离心5分钟;
8.离心完毕,弃上清,干燥沉淀至无乙醇气味.
注：第3，第4步可以用PCR 纯化试剂盒代替。
PCR纯化试剂盒操作流程：
1．溶液PE使用前应加入适量体积95％－100％的乙醇，混匀。
2．向200ul二链补平产物中加入5倍体积的buffer PB，混匀。
3．加入spin column中，13000rpm离心1min。
4．加入0.75ml buffer PE，13000rpm离心1min。
5．13000rpm，再离心1min。
6．将spin column放入一新的离心管中，加入50ul buffer EB，静置10min。
7．13000rpm离心2min。
8．加入30ul buffer EB，静置10min。
9．13000rpm离心2min。
10．加入1/10体积3M的NaAc，2.5倍体积无水乙醇，混匀，－20℃沉淀过夜。
